|
Number of patients expressing E-Cadherin and β-Catenin among the various histologic subtypes |
||||||
| Histologic subtype of cervical carcinoma |
Preserved¶ |
Impaired |
U |
|||
|
|
||||||
| Reduced Staining ▼ |
Exclu-Sively Cyto-Plasmic Stain Ing |
Negative Staining |
Nuclear Staining |
|||
|
|
||||||
| β-catenin expression |
||||||
|
|
||||||
| Squamous cell Carcinoma (n = 96) |
29 |
10 |
2 |
52 |
0 |
3 |
| Adenocarcinoma (n = 35) |
5 |
7 |
1 |
22 |
0 |
0 |
| Adenosquamous (n = 12) |
5 |
1 |
2 |
4 |
0 |
0 |
| Others (n = 4) |
1 |
1 |
0 |
1 |
0 |
1 |
| Total (n = 147) |
40 |
19 |
5 |
79 |
0 |
4 |
|
|
||||||
| E-cadherin expression |
||||||
|
|
||||||
| Squamous cell Carcinoma (n = 96) |
11 |
16 |
2 |
65 |
0 |
2 |
| Adenocarcinoma (n = 35) |
1 |
5 |
3 |
25 |
0 |
1 |
| Adenosquamous (n = 12) |
0 |
3 |
2 |
7 |
0 |
0 |
| Others (n = 4) |
1 |
0 |
1 |
2 |
0 |
0 |
| Total (n = 147) |
13 |
24 |
8 |
98 |
0 |
4 |
|
U: unsatisfactory ¶ membranous staining with 200 score or higher ▼less than 200 score | ||||||
Fadare et al. World Journal of Surgical Oncology 2005 3:38 doi:10.1186/1477-7819-3-38 |
||||||